Patent · US Active

Pyrazolopyrimidine derivatives

US8741896B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Hans-Peter Buchstaller · Griesheim, DE
Ulrich Emde · Darmstadt, DE
Markus Klein · Weiterstadt, DE
Christina Esdar · Darmstadt, DE
Joerg Bomke · Heidelberg, DE

Key dates

Filing date	Sep 24, 2010
Grant date	Jun 3, 2014
Priority date	—
Expiry date	Dec 31, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula (I), in which X, R1 and R2 have the meanings indicated in claim 1, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.